Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Meridian Bioscience, Inc. (VIVO)

33.97   0 (0%) 01-30 16:00
Open: 33.95 Pre. Close: 33.97
High: 34.01 Low: 33.95
Volume: 5,627,450 Market Cap: 1,489(M)

Technical analysis

as of: 2023-03-03 4:53:42 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 39.72     One year: 46.39
Support: Support1: 33.44    Support2: 33.09
Resistance: Resistance1: 34    Resistance2: 39.72
Pivot: 33.77
Moving Average: MA(5): 33.96     MA(20): 33.69
MA(100): 32.48     MA(250): 30.04
MACD: MACD(12,26): 0.2     Signal(9): 0.2
Stochastic oscillator: %K(14,3): 93.6     %D(3): 95.5
RSI: RSI(14): 71.2
52-week: High: 34.38  Low: 23.44
Average Vol(K): 3-Month: 621 (K)  10-Days: 1,323 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ VIVO ] has closed below upper band by 17.8%. Bollinger Bands are 42.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 34.02 - 34.19 34.19 - 34.33
Low: 33.57 - 33.75 33.75 - 33.9
Close: 33.7 - 33.99 33.99 - 34.23

Company Description

Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the LeadCare brands; and urea breath testing for H. pylori under the BreathID and BreathTek brand. This segment also offers respiratory illness assays, such as tests Group A strep, mycoplasma pneumonia, influenza, and pertussis; and blood chemistry products for LeadCare test kits for the detection of lead in blood. It sells products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers, as well as researchers in immunological and molecular tests for human, animal, plant, and environmental applications. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio.

Headline News

Thu, 30 Mar 2023
HFMD Test Kits Market Booming Worldwide( Forecast Period 2023-2029) With Top Player:Abbot, BD, BioMerieux - openPR

Tue, 31 Jan 2023
SD Biosensor and SJL Partners Complete Transaction to Acquire ... - PR Newswire

Tue, 13 Dec 2022
Meridian Biosciences Stock: Why I Moved On But May Go Back In ... - Seeking Alpha

Mon, 12 Dec 2022
Meridian Bioscience Announces Anticipated Closing Date of the ... - PR Newswire

Tue, 22 Nov 2022

Fri, 05 Aug 2022

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. 44 (M)
Shares Float 41 (M)
% Held by Insiders 1.3 (%)
% Held by Institutions 90.9 (%)
Shares Short 4,240 (K)
Shares Short P.Month 3,430 (K)

Stock Financials

EPS 1.61
EPS Est Next Qtl 0.15
EPS Est This Year 0.67
EPS Est Next Year 0.67
Book Value (p.s.) 6.46
Profit Margin (%) 12.7
Operating Margin (%) 22.7
Return on Assets (ttm) 10.3
Return on Equity (ttm) 12.1
Qtrly Rev. Growth -13.9
Gross Profit (p.s.) 4.29
Sales Per Share 7.59
EBITDA (p.s.) 2.1
Qtrly Earnings Growth -13
Operating Cash Flow 82 (M)
Levered Free Cash Flow 86 (M)

Stock Valuations

PE Ratio 21.09
PEG Ratio 2.5
Price to Book value 5.25
Price to Sales 4.47
Price to Cash Flow 18.07

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2019-02-13
Ex-Dividend Date 2019-01-31
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.